Research using the db/db mouse model, which simulates obesity, has shown increased levels of GLP1 can reduce histological signs of tubulointerstitial damage and decrease the renal expression of proinflammatory markers such as TNFα and Ccl5. This evidence concerns the gene GCG and obesity disorder.